Avista exits Inform Diagnostics

Avista Capital Partners has sold Inform Diagnostics to Fulgent Genetics for about $170 million.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this